Oral finasteride improved the quality of life of androgenetic alopecia patients

Journal of Dermatology

Volumn 38, Issue 8, 2011, Pages 773-777

  Yamazaki, Masashi ^a   Miyakura, Takashi ^a   Uchiyama, Masaki ^a   Hobo, Ayako ^a   Irisawa, Ryokichi ^a   Tsuboi, Ryoji ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

androgenetic alopecia; dermatology life quality index; quality of life; State Trait Anxiety Inventory; Visual Analog Scale; WHO QOL 26

Indexed keywords

FINASTERIDE;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; HUMAN; MALE; MALE TYPE ALOPECIA; PHYSICIAN; QUALITY OF LIFE; QUESTIONNAIRE; SENSITIVITY ANALYSIS; STATE TRAIT ANXIETY INVENTORY; VISUAL ANALOG SCALE;

5-ALPHA REDUCTASE INHIBITORS; ADMINISTRATION, ORAL; ADULT; AGED; ALOPECIA; FINASTERIDE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 79961051170     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.01126.x     Document Type: Article

References (17)

1. Norwood O,. Male pattern baldness: classification and incidence. South Med J 1975; 68: 1359-1365.
2. Girman CJ, Rhodes T, Lilly FR, et al. Effects of self-perceived hair loss in a community sample of men. Dermatolog 1998; 197: 223-229. (Pubitemid 28445819)
3. Finlay AY, Khan GK,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216. (Pubitemid 24194579)
4. Nakane Y, Tazaki M, Miyaoka E,. WHOQOL-BREF survey of general population. Iryo to Shakai 1999; 9: 123-131. (in Japanese.)
5. Nakazato K, Shimonaka Y,. The Japanese State-Trait Anxiety Inventory: age and sex differences. Percept Mot Skills 1989; 69: 611-617. (Pubitemid 19277075)
6. Van der Donk J, Passchier J, Dutree-Meulenberg RO, et al. Psychologic characteristics of men with alopecia androgenetica and their modification. Int J Dermatol 1991; 30: 22-28.
7. Cash TF,. The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol 1992; 26: 926-931.
8. Wells PA, Willmoth T, Russell RJ,. Does fortune favour the bald? Psychological correlates of hair loss in males. Br J Psychol 1995; 86: 337-344. (Pubitemid 126418058)
9. Maffei C, Fossati A, Rinaldi F, Riva E,. Personality disorders and psychopathologic symptoms in patients with androgenetic alopecia. Arch Dermatol 1994; 130: 868-872. (Pubitemid 24225839)
10. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998; 39: 578-589. (Pubitemid 28465881)
11. Leyden J, Dunlap F, Miller B, et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol 1999; 40: 930-937. (Pubitemid 29268924)
12. Finasteride Male Pattern Hair Loss Study Group. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol 2002; 12: 38-49.
13. Cartwright T, Endean N, Porter A,. Illness perceptions, coping and quality of life in patients with alopecia. Br J Dermatol 2009; 160: 1034-1039.
14. Hahn HB, Melfi CA, Chuang TY, et al. Use of the Dermatology life quality index (DLQI) in a Midwestern US urban clinic. J Am Acad Dermatol 2001; 45: 44-48. (Pubitemid 32655691)
15. Tsuboi R, Itoh M, Ito H, et al. Improvement of QOL of vitiligo patients using male-up cosmetic to conceal hypopigmentation. Skin Res 2006; 5: 71-79. (in Japanese.)
16. Hayashi N, Imori M, Yanagisawa M, et al. Make-up improves the quality of life of acne patients without aggravating acne eruptions during treatments. Eur J Dermatol 2005; 15: 284-287. (Pubitemid 41020859)
17. Arikawa J, Hashiba S, Ohshiro K, Kawashima M,. The effects of make-up on QOL of female patients with atopic dermatitis. Jpn J Clin Dermatol 2003; 57: 224-230. (in Japanese.)